Core Laboratories
CLB
372 hedge funds and large institutions have $5.08B invested in Core Laboratories in 2016 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 150 increasing their positions, 125 reducing their positions, and 40 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 150 | Existing positions reduced: 125
0.73% less ownership
Funds ownership: 103.41% → 102.68% (-0.73%)
3% less funds holding
Funds holding: 383 → 372 (-11)
11% less capital invested
Capital invested by funds: $5.71B → $5.08B (-$621M)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
20% less call options, than puts
Call options by funds: $28M | Put options by funds: $34.9M
20% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 40
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$45.9M |
| 2 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$44.9M |
| 3 |
APG Asset Management
Amsterdam,
Netherlands
|
+$28.9M |
| 4 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
+$25.5M |
| 5 |
MVIP
Mar Vista Investment Partners
Los Angeles,
California
|
+$25.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$132M |
| 2 |
EIP
Epoch Investment Partners
New York
|
-$72M |
| 3 |
Bessemer Group
Woodbridge,
New Jersey
|
-$63.3M |
| 4 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$44M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$18.4M |
CLB Hedge Fund Activity: Q3 2016 in Review
372 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q3 2016, worth a combined $5.08B — down 11% from $5.71B a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of CLB and 32 opened new positions — a net loss of 8 holders — while 125 trimmed existing stakes and 150 added.
The largest buyer was Norges Bank, adding an estimated $45.9M. The largest seller was Macquarie Group, cutting an estimated $132M.
- 372 institutional investors held Core Laboratories (CLB) as of Q3 2016, down from 383 in Q2 2016.
- Funds reported $5.08B of Core Laboratories stock for Q3 2016, down 11% quarter-over-quarter.
- 32 funds opened new Core Laboratories positions in Q3 2016 and 40 closed out, a net change of -8 holders.
- The largest Core Laboratories buyer in Q3 2016 was Norges Bank, an estimated $45.9M added.
- The largest Core Laboratories seller in Q3 2016 was Macquarie Group, an estimated $132M sold.
Based on aggregated 13F filings for Q3 2016.